Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis. Article Swipe
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.36141/svdld.v35i4.6855
Background: In sarcoidosis patients, pulmonary hypertension (PH) is associated with significant morbidity and mortality. Early identification of sarcoidosis-associated pulmonary hypertension (SAPH) has substantial clinical implications. While a number of pulmonary function testing (PFT) variables have been associated with SAPH, the optimal use of PFT's in screening for SAPH is unknown. Objectives: To examine the predictive value of PFT's for echocardiographic PH in a cohort of sarcoidosis patients. Methods: We conducted a retrospective cohort study of patients with sarcoidosis from a single center over a period of five years. All consecutive adult patients with a diagnosis of biopsy-proven sarcoidosis (determined by review of the medical chart) who underwent PFT and echocardiographic testing were included. Echocardiographic risk of PH (either intermediate or high) was determined by the presence of echocardiographic PH signs and tricuspid regurgitant jet velocity. Data analysis was performed using multivariate logistic regression analysis with least absolute shrinkage and selection operator. Results: Of the 156 patients included in the study, 42 (27%) met the criteria for echocardiographic PH. Roughly equal proportions met the criteria for intermediate risk (45%) as did for high risk of PH (55%). The percent predicted of diffusion capacity for carbon monoxide (%DLCO) and forced vital capacity (%FVC) were predictive of echocardiographic PH. No other PFT variables outperformed these two markers, and the incorporation of additional PFT variables failed to significantly enhance the model. Conclusions: The %FVC and %DLCO emerged as being predictive of echocardiographic PH in this cohort of biopsy-proven sarcoidosis patients. Potentially reflecting the multifactorial pathogenesis of PH in sarcoidosis, incorporation of other PFT variables failed to enhance screening for PH in this population. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 308-316).
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://pubmed.ncbi.nlm.nih.gov/32476918
- OA Status
- green
- Cited By
- 3
- References
- 24
- Related Works
- 20
- OpenAlex ID
- https://openalex.org/W2804878083
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2804878083Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.36141/svdld.v35i4.6855Digital Object Identifier
- Title
-
Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis.Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-01-01Full publication date if available
- Authors
-
Arun Jose, Joseph Delio, Jonathan Gwizdala, Hannah Goulart, Jalil AhariList of authors in order
- Landing page
-
https://pubmed.ncbi.nlm.nih.gov/32476918Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/7170124Direct OA link when available
- Concepts
-
Medicine, DLCO, Sarcoidosis, Pulmonary hypertension, Cohort, Pulmonary function testing, Internal medicine, Cardiology, Spirometry, Vital capacity, Logistic regression, Retrospective cohort study, Diffusing capacity, Lung, Lung function, AsthmaTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2021: 2Per-year citation counts (last 5 years)
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
20Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2804878083 |
|---|---|
| doi | https://doi.org/10.36141/svdld.v35i4.6855 |
| ids.mag | 2804878083 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/32476918 |
| ids.openalex | https://openalex.org/W2804878083 |
| fwci | 0.33908021 |
| type | article |
| title | Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis. |
| biblio.issue | 4 |
| biblio.volume | 35 |
| biblio.last_page | 316 |
| biblio.first_page | 308 |
| topics[0].id | https://openalex.org/T11571 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Sarcoidosis and Beryllium Toxicity Research |
| topics[1].id | https://openalex.org/T10870 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| topics[2].id | https://openalex.org/T10728 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9987999796867371 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Pulmonary Hypertension Research and Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9238682985305786 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C16020263 |
| concepts[1].level | 5 |
| concepts[1].score | 0.8094065189361572 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1778553 |
| concepts[1].display_name | DLCO |
| concepts[2].id | https://openalex.org/C2781301800 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7563607096672058 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q193894 |
| concepts[2].display_name | Sarcoidosis |
| concepts[3].id | https://openalex.org/C2780930700 |
| concepts[3].level | 2 |
| concepts[3].score | 0.7075616121292114 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1128595 |
| concepts[3].display_name | Pulmonary hypertension |
| concepts[4].id | https://openalex.org/C72563966 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6758410334587097 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[4].display_name | Cohort |
| concepts[5].id | https://openalex.org/C75603125 |
| concepts[5].level | 2 |
| concepts[5].score | 0.6739773154258728 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1877462 |
| concepts[5].display_name | Pulmonary function testing |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.6193217635154724 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C164705383 |
| concepts[7].level | 1 |
| concepts[7].score | 0.5780913829803467 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[7].display_name | Cardiology |
| concepts[8].id | https://openalex.org/C2780333948 |
| concepts[8].level | 3 |
| concepts[8].score | 0.5529525279998779 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q653305 |
| concepts[8].display_name | Spirometry |
| concepts[9].id | https://openalex.org/C55520419 |
| concepts[9].level | 5 |
| concepts[9].score | 0.5261737108230591 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q660995 |
| concepts[9].display_name | Vital capacity |
| concepts[10].id | https://openalex.org/C151956035 |
| concepts[10].level | 2 |
| concepts[10].score | 0.5176175832748413 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1132755 |
| concepts[10].display_name | Logistic regression |
| concepts[11].id | https://openalex.org/C167135981 |
| concepts[11].level | 2 |
| concepts[11].score | 0.47832489013671875 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[11].display_name | Retrospective cohort study |
| concepts[12].id | https://openalex.org/C165637977 |
| concepts[12].level | 4 |
| concepts[12].score | 0.350846529006958 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11067835 |
| concepts[12].display_name | Diffusing capacity |
| concepts[13].id | https://openalex.org/C2777714996 |
| concepts[13].level | 2 |
| concepts[13].score | 0.30190950632095337 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7886 |
| concepts[13].display_name | Lung |
| concepts[14].id | https://openalex.org/C3018587741 |
| concepts[14].level | 3 |
| concepts[14].score | 0.11514481902122498 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7886 |
| concepts[14].display_name | Lung function |
| concepts[15].id | https://openalex.org/C2776042228 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q35869 |
| concepts[15].display_name | Asthma |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9238682985305786 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/dlco |
| keywords[1].score | 0.8094065189361572 |
| keywords[1].display_name | DLCO |
| keywords[2].id | https://openalex.org/keywords/sarcoidosis |
| keywords[2].score | 0.7563607096672058 |
| keywords[2].display_name | Sarcoidosis |
| keywords[3].id | https://openalex.org/keywords/pulmonary-hypertension |
| keywords[3].score | 0.7075616121292114 |
| keywords[3].display_name | Pulmonary hypertension |
| keywords[4].id | https://openalex.org/keywords/cohort |
| keywords[4].score | 0.6758410334587097 |
| keywords[4].display_name | Cohort |
| keywords[5].id | https://openalex.org/keywords/pulmonary-function-testing |
| keywords[5].score | 0.6739773154258728 |
| keywords[5].display_name | Pulmonary function testing |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.6193217635154724 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/cardiology |
| keywords[7].score | 0.5780913829803467 |
| keywords[7].display_name | Cardiology |
| keywords[8].id | https://openalex.org/keywords/spirometry |
| keywords[8].score | 0.5529525279998779 |
| keywords[8].display_name | Spirometry |
| keywords[9].id | https://openalex.org/keywords/vital-capacity |
| keywords[9].score | 0.5261737108230591 |
| keywords[9].display_name | Vital capacity |
| keywords[10].id | https://openalex.org/keywords/logistic-regression |
| keywords[10].score | 0.5176175832748413 |
| keywords[10].display_name | Logistic regression |
| keywords[11].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[11].score | 0.47832489013671875 |
| keywords[11].display_name | Retrospective cohort study |
| keywords[12].id | https://openalex.org/keywords/diffusing-capacity |
| keywords[12].score | 0.350846529006958 |
| keywords[12].display_name | Diffusing capacity |
| keywords[13].id | https://openalex.org/keywords/lung |
| keywords[13].score | 0.30190950632095337 |
| keywords[13].display_name | Lung |
| keywords[14].id | https://openalex.org/keywords/lung-function |
| keywords[14].score | 0.11514481902122498 |
| keywords[14].display_name | Lung function |
| language | en |
| locations[0].id | pmid:32476918 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4306525036 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | PubMed |
| locations[0].source.host_organization | https://openalex.org/I1299303238 |
| locations[0].source.host_organization_name | National Institutes of Health |
| locations[0].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG |
| locations[0].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/32476918 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:7170124 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Sarcoidosis Vasc Diffuse Lung Dis |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7170124 |
| locations[2].id | mag:2804878083 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S157329216 |
| locations[2].source.issn | 1124-0490, 2532-179X |
| locations[2].source.type | journal |
| locations[2].source.is_oa | True |
| locations[2].source.issn_l | 1124-0490 |
| locations[2].source.is_core | True |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Sarcoidosis vasculitis and diffuse lung diseases |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | |
| locations[2].raw_type | |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | |
| locations[2].raw_source_name | Sarcoidosis vasculitis and diffuse lung diseases |
| locations[2].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/32476918/ |
| indexed_in | pubmed |
| authorships[0].author.id | https://openalex.org/A5011538718 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7109-2692 |
| authorships[0].author.display_name | Arun Jose |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210154614, https://openalex.org/I4210165183 |
| authorships[0].affiliations[0].raw_affiliation_string | Pulmonary, Critical Care, and Sleep Medicine Division and. |
| authorships[0].institutions[0].id | https://openalex.org/I4210165183 |
| authorships[0].institutions[0].ror | https://ror.org/05qwgjf62 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210165183 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Pulmonary and Critical Care Associates |
| authorships[0].institutions[1].id | https://openalex.org/I4210154614 |
| authorships[0].institutions[1].ror | https://ror.org/04bxj6908 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210154614 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | SleepMed |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Arun Jose |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Pulmonary, Critical Care, and Sleep Medicine Division and. |
| authorships[1].author.id | https://openalex.org/A5082909943 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2540-8945 |
| authorships[1].author.display_name | Joseph Delio |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I193531525 |
| authorships[1].affiliations[0].raw_affiliation_string | Internal Medicine Division, The George Washington University MFA, Washington D.C. |
| authorships[1].institutions[0].id | https://openalex.org/I193531525 |
| authorships[1].institutions[0].ror | https://ror.org/00y4zzh67 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I193531525 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | George Washington University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Joseph Delio |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Internal Medicine Division, The George Washington University MFA, Washington D.C. |
| authorships[2].author.id | https://openalex.org/A5062593312 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Jonathan Gwizdala |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I193531525 |
| authorships[2].affiliations[0].raw_affiliation_string | Internal Medicine Division, The George Washington University MFA, Washington D.C. |
| authorships[2].institutions[0].id | https://openalex.org/I193531525 |
| authorships[2].institutions[0].ror | https://ror.org/00y4zzh67 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I193531525 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | George Washington University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jonathan Gwizdala |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Internal Medicine Division, The George Washington University MFA, Washington D.C. |
| authorships[3].author.id | https://openalex.org/A5085198900 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-1945-2571 |
| authorships[3].author.display_name | Hannah Goulart |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I193531525 |
| authorships[3].affiliations[0].raw_affiliation_string | The School of Medicine, George Washington University, Washington D.C. |
| authorships[3].institutions[0].id | https://openalex.org/I193531525 |
| authorships[3].institutions[0].ror | https://ror.org/00y4zzh67 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I193531525 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | George Washington University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hannah Goulart |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | The School of Medicine, George Washington University, Washington D.C. |
| authorships[4].author.id | https://openalex.org/A5108981724 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2794-3773 |
| authorships[4].author.display_name | Jalil Ahari |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210154614, https://openalex.org/I4210165183 |
| authorships[4].affiliations[0].raw_affiliation_string | Pulmonary, Critical Care, and Sleep Medicine Division and. |
| authorships[4].institutions[0].id | https://openalex.org/I4210165183 |
| authorships[4].institutions[0].ror | https://ror.org/05qwgjf62 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210165183 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Pulmonary and Critical Care Associates |
| authorships[4].institutions[1].id | https://openalex.org/I4210154614 |
| authorships[4].institutions[1].ror | https://ror.org/04bxj6908 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210154614 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | SleepMed |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Jalil E. Ahari |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Pulmonary, Critical Care, and Sleep Medicine Division and. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7170124 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis. |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11571 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Sarcoidosis and Beryllium Toxicity Research |
| related_works | https://openalex.org/W2799505066, https://openalex.org/W2330481161, https://openalex.org/W2144939236, https://openalex.org/W2736099131, https://openalex.org/W2565587524, https://openalex.org/W3096878407, https://openalex.org/W3022944302, https://openalex.org/W2135806624, https://openalex.org/W2906590949, https://openalex.org/W2065992553, https://openalex.org/W2324311842, https://openalex.org/W2778373451, https://openalex.org/W2327134478, https://openalex.org/W2989573825, https://openalex.org/W3034926963, https://openalex.org/W2111195342, https://openalex.org/W3025902189, https://openalex.org/W3177502434, https://openalex.org/W3164735815, https://openalex.org/W3010601507 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:7170124 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Sarcoidosis Vasc Diffuse Lung Dis |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7170124 |
| primary_location.id | pmid:32476918 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4306525036 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | PubMed |
| primary_location.source.host_organization | https://openalex.org/I1299303238 |
| primary_location.source.host_organization_name | National Institutes of Health |
| primary_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG |
| primary_location.landing_page_url | https://pubmed.ncbi.nlm.nih.gov/32476918 |
| publication_date | 2018-01-01 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W1494411849, https://openalex.org/W2591454692, https://openalex.org/W1525224736, https://openalex.org/W2130932769, https://openalex.org/W2016978338, https://openalex.org/W2004400845, https://openalex.org/W2094338449, https://openalex.org/W2465401158, https://openalex.org/W2161370807, https://openalex.org/W2395995666, https://openalex.org/W2161483623, https://openalex.org/W2097551954, https://openalex.org/W1963677467, https://openalex.org/W2167453600, https://openalex.org/W2095934572, https://openalex.org/W2509242824, https://openalex.org/W2477785160, https://openalex.org/W2026933224, https://openalex.org/W2074372507, https://openalex.org/W2217894778, https://openalex.org/W2150310968, https://openalex.org/W2183644045, https://openalex.org/W2618255833, https://openalex.org/W2017814194 |
| referenced_works_count | 24 |
| abstract_inverted_index.a | 26, 62, 70, 79, 83, 93 |
| abstract_inverted_index.42 | 160 |
| abstract_inverted_index.In | 1 |
| abstract_inverted_index.No | 206 |
| abstract_inverted_index.Of | 152 |
| abstract_inverted_index.PH | 60, 116, 128, 184, 238, 252, 265 |
| abstract_inverted_index.To | 51 |
| abstract_inverted_index.We | 68 |
| abstract_inverted_index.as | 178, 233 |
| abstract_inverted_index.by | 99, 123 |
| abstract_inverted_index.in | 44, 61, 157, 239, 253, 266 |
| abstract_inverted_index.is | 7, 48 |
| abstract_inverted_index.of | 16, 28, 42, 56, 64, 74, 85, 95, 101, 115, 126, 183, 189, 203, 217, 236, 242, 251, 256 |
| abstract_inverted_index.or | 119 |
| abstract_inverted_index.to | 222, 261 |
| abstract_inverted_index.156 | 154 |
| abstract_inverted_index.35: | 275 |
| abstract_inverted_index.All | 88 |
| abstract_inverted_index.Dis | 273 |
| abstract_inverted_index.PFT | 107, 208, 219, 258 |
| abstract_inverted_index.PH. | 167, 205 |
| abstract_inverted_index.The | 186, 228 |
| abstract_inverted_index.and | 12, 108, 130, 148, 196, 214, 230 |
| abstract_inverted_index.did | 179 |
| abstract_inverted_index.for | 46, 58, 165, 174, 180, 192, 264 |
| abstract_inverted_index.has | 21 |
| abstract_inverted_index.jet | 133 |
| abstract_inverted_index.met | 162, 171 |
| abstract_inverted_index.the | 39, 53, 102, 124, 153, 158, 163, 172, 215, 225, 248 |
| abstract_inverted_index.two | 212 |
| abstract_inverted_index.use | 41 |
| abstract_inverted_index.was | 121, 137 |
| abstract_inverted_index.who | 105 |
| abstract_inverted_index.%FVC | 229 |
| abstract_inverted_index.(PH) | 6 |
| abstract_inverted_index.Data | 135 |
| abstract_inverted_index.Lung | 272 |
| abstract_inverted_index.SAPH | 47 |
| abstract_inverted_index.Vasc | 270 |
| abstract_inverted_index.been | 35 |
| abstract_inverted_index.five | 86 |
| abstract_inverted_index.from | 78 |
| abstract_inverted_index.have | 34 |
| abstract_inverted_index.high | 181 |
| abstract_inverted_index.over | 82 |
| abstract_inverted_index.risk | 114, 176, 182 |
| abstract_inverted_index.this | 240, 267 |
| abstract_inverted_index.were | 111, 201 |
| abstract_inverted_index.with | 9, 37, 76, 92, 144 |
| abstract_inverted_index.%DLCO | 231 |
| abstract_inverted_index.(27%) | 161 |
| abstract_inverted_index.(45%) | 177 |
| abstract_inverted_index.(PFT) | 32 |
| abstract_inverted_index.2018; | 274 |
| abstract_inverted_index.Early | 14 |
| abstract_inverted_index.PFT's | 43, 57 |
| abstract_inverted_index.SAPH, | 38 |
| abstract_inverted_index.While | 25 |
| abstract_inverted_index.adult | 90 |
| abstract_inverted_index.being | 234 |
| abstract_inverted_index.equal | 169 |
| abstract_inverted_index.high) | 120 |
| abstract_inverted_index.least | 145 |
| abstract_inverted_index.other | 207, 257 |
| abstract_inverted_index.signs | 129 |
| abstract_inverted_index.study | 73 |
| abstract_inverted_index.these | 211 |
| abstract_inverted_index.using | 139 |
| abstract_inverted_index.value | 55 |
| abstract_inverted_index.vital | 198 |
| abstract_inverted_index.(%FVC) | 200 |
| abstract_inverted_index.(55%). | 185 |
| abstract_inverted_index.(SAPH) | 20 |
| abstract_inverted_index.carbon | 193 |
| abstract_inverted_index.center | 81 |
| abstract_inverted_index.chart) | 104 |
| abstract_inverted_index.cohort | 63, 72, 241 |
| abstract_inverted_index.failed | 221, 260 |
| abstract_inverted_index.forced | 197 |
| abstract_inverted_index.model. | 226 |
| abstract_inverted_index.number | 27 |
| abstract_inverted_index.period | 84 |
| abstract_inverted_index.review | 100 |
| abstract_inverted_index.single | 80 |
| abstract_inverted_index.study, | 159 |
| abstract_inverted_index.years. | 87 |
| abstract_inverted_index.(%DLCO) | 195 |
| abstract_inverted_index.(either | 117 |
| abstract_inverted_index.Diffuse | 271 |
| abstract_inverted_index.Roughly | 168 |
| abstract_inverted_index.emerged | 232 |
| abstract_inverted_index.enhance | 224, 262 |
| abstract_inverted_index.examine | 52 |
| abstract_inverted_index.medical | 103 |
| abstract_inverted_index.optimal | 40 |
| abstract_inverted_index.percent | 187 |
| abstract_inverted_index.testing | 31, 110 |
| abstract_inverted_index.absolute | 146 |
| abstract_inverted_index.analysis | 136, 143 |
| abstract_inverted_index.capacity | 191, 199 |
| abstract_inverted_index.clinical | 23 |
| abstract_inverted_index.criteria | 164, 173 |
| abstract_inverted_index.function | 30 |
| abstract_inverted_index.included | 156 |
| abstract_inverted_index.logistic | 141 |
| abstract_inverted_index.markers, | 213 |
| abstract_inverted_index.monoxide | 194 |
| abstract_inverted_index.patients | 75, 91, 155 |
| abstract_inverted_index.presence | 125 |
| abstract_inverted_index.unknown. | 49 |
| abstract_inverted_index.conducted | 69 |
| abstract_inverted_index.diagnosis | 94 |
| abstract_inverted_index.diffusion | 190 |
| abstract_inverted_index.included. | 112 |
| abstract_inverted_index.morbidity | 11 |
| abstract_inverted_index.operator. | 150 |
| abstract_inverted_index.patients, | 3 |
| abstract_inverted_index.patients. | 66, 245 |
| abstract_inverted_index.performed | 138 |
| abstract_inverted_index.predicted | 188 |
| abstract_inverted_index.pulmonary | 4, 18, 29 |
| abstract_inverted_index.screening | 45, 263 |
| abstract_inverted_index.selection | 149 |
| abstract_inverted_index.shrinkage | 147 |
| abstract_inverted_index.tricuspid | 131 |
| abstract_inverted_index.underwent | 106 |
| abstract_inverted_index.variables | 33, 209, 220, 259 |
| abstract_inverted_index.velocity. | 134 |
| abstract_inverted_index.additional | 218 |
| abstract_inverted_index.associated | 8, 36 |
| abstract_inverted_index.determined | 122 |
| abstract_inverted_index.mortality. | 13 |
| abstract_inverted_index.predictive | 54, 202, 235 |
| abstract_inverted_index.reflecting | 247 |
| abstract_inverted_index.regression | 142 |
| abstract_inverted_index.(determined | 98 |
| abstract_inverted_index.Potentially | 246 |
| abstract_inverted_index.consecutive | 89 |
| abstract_inverted_index.population. | 268 |
| abstract_inverted_index.proportions | 170 |
| abstract_inverted_index.regurgitant | 132 |
| abstract_inverted_index.sarcoidosis | 2, 65, 77, 97, 244 |
| abstract_inverted_index.significant | 10 |
| abstract_inverted_index.substantial | 22 |
| abstract_inverted_index.hypertension | 5, 19 |
| abstract_inverted_index.intermediate | 118, 175 |
| abstract_inverted_index.multivariate | 140 |
| abstract_inverted_index.outperformed | 210 |
| abstract_inverted_index.pathogenesis | 250 |
| abstract_inverted_index.sarcoidosis, | 254 |
| abstract_inverted_index.308-316)</i>. | 276 |
| abstract_inverted_index.biopsy-proven | 96, 243 |
| abstract_inverted_index.implications. | 24 |
| abstract_inverted_index.incorporation | 216, 255 |
| abstract_inverted_index.retrospective | 71 |
| abstract_inverted_index.significantly | 223 |
| abstract_inverted_index.identification | 15 |
| abstract_inverted_index.multifactorial | 249 |
| abstract_inverted_index.<i>(Sarcoidosis | 269 |
| abstract_inverted_index.<i>Methods:</i> | 67 |
| abstract_inverted_index.<i>Results:</i> | 151 |
| abstract_inverted_index.Echocardiographic | 113 |
| abstract_inverted_index.echocardiographic | 59, 109, 127, 166, 204, 237 |
| abstract_inverted_index.<i>Background:</i> | 0 |
| abstract_inverted_index.<i>Objectives:</i> | 50 |
| abstract_inverted_index.<i>Conclusions:</i> | 227 |
| abstract_inverted_index.sarcoidosis-associated | 17 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile.value | 0.57898671 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |